Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Chesapeake Energy: The Stock Is Going From Bad To Worse

By Ian Bezek, InvestorPlace Contributor
Chesapeake Energy is trading at its lowest stock price of this century. And there's no guarantee that shares will ever recover as solvency questions loom.

Avoid FuelCell Energy Stock Even If You’re Bullish on Clean Energy

By David Moadel, InvestorPlace Contributor
There are more promising alternatives to FuelCell Energy when it comes to investments in the alternative-energy movement. Avoid FCEL stock.

Acasti Pharma Stock Is Bleeding Both Value and Credibility

By Josh Enomoto, InvestorPlace Contributor
Acasti Pharma stock jumped higher last year on the potential of Acasti’s krill-oil extract CaPre. But a closer examination of its Phase 3 results suggests not all is well with the company.

Coronavirus Worries Will Undercut the Nio Stock Recovery

By Tom Taulli, InvestorPlace Contributor
Nio has been in the rally mode. But this is likely to fade. Here’s a look at the key reasons.

Activision Blizzard Stock Still Has a Serious Growth Problem

By Vince Martin, InvestorPlace Contributor
Activision Blizzard stock has rallied to a 52-week high, but its stagnant business suggests ATVI stock is overvalued.

There’s No Miraculous Comeback Looming for Acasti Pharma Stock

By Todd Shriber, InvestorPlace Contributor
Acasti's Phase 3 trial of CaPre, aimed at patients with high levels of triglycerides, isn't working out, explaining why the stock is down 69.11% to start 2020. One of the primary causes of concern with the Trilogy 1 Phase 3 trial of CaPre was that there were unanticipated levels of placebo response. Said another way, patients got a cornstarch pill, which of course would be far less expensive than any drug, and had a positive reaction to it.

Beware the Hype: Plug Power Stock Isn’t the Next Tesla

By Ian Bezek, InvestorPlace Contributor
PLUG stock has been jumping in sympathy with Tesla stock. But as the hype fades, expect PLUG's shares to sink.

Pier 1’s Struggles Mark the End of a Major Retailing Era

By Dana Blankenhorn, InvestorPlace Contributor
Pier 1 is closing half its stores and trying to become an "omni-channel" retailer, but it's about 10 years too late. Sell PIR stock now.

Alcoa Stock Likely To Remain Depressed Under Macro Concerns

By Faisal Humayun, InvestorPlace Contributor
Weak GDP growth in 2020 will translate into aluminum surplus, lower prices and pressure on margins for Alcoa stock.

Peloton Is One Battle the Short Sellers Are Winning Now

By Dana Blankenhorn, InvestorPlace Contributor
Peloton believes its video exercise service can still be a big success, but Peloton stock's enormous short ratio shows skepticism abounds.

Here’s Why Investors Should Take Profits on AMD Stock Now

By Larry Ramer, InvestorPlace Contributor
AMD is facing many challenges, including steeper competition and its apparent disadvantage in AI. As a result, I recommend selling AMD stock.

TXN Stock Is Too Exposed to China Headwinds

By Brad Moon, InvestorPlace Contributor
TXN stock may have enjoyed some positive sessions recently. But the underlying tech firm is too exposed to dangerous China-related headwinds.

Management Failures Continue to Be a Drag on UA Stock

By Jonathan Berr, InvestorPlace Contributor
Accounting irregularities, a toxic work culture and ignoring the athleisure trend are just a few reasons to avoid UA stock.

The Rally in Spotify Stock Looks Like It’s Going to Stall out at $150

By Luke Lango, InvestorPlace Senior Investment Analyst
Here and now, Spotify stock is fully valued, technically maxed out, and staring at escalating profit headwinds.

Under Debt Obligations, Chesapeake Energy Stock Isn’t Worth the Risk

By Marie Brodbeck, InvestorPlace Contributor
CHK stock is too risky to bet on right now, especially with the oil and gas industry facing so many headwinds

It’s No Surprise Aurora Cannabis Stock Is Near Its All-Time Lows

By Bret Kenwell, InvestorPlace Contributor
Aurora stock could take out its lows after its CEO departed and it unveiled worse-than-expected second-quarter results.

Despite the Q4 Win, It’s Time to Sell General Electric Stock

By Patrick Sanders, InvestorPlace Contributor
General Electric's time as a star company has come and gone. There are better options out there than GE stock.

Is Apple Stock Finally Starting to Stall?

By Tom Taulli, InvestorPlace Contributor
Apple stock has had an epic run. But going forward, it could get more difficult to churn out the gains. Here’s a look at why.

CHK Stock Is on the Wrong End of a Megatrend

By InvestorPlace Research Staff
CHK stock was relevant when the underlying oil market was booming. But with supply rising sharply due to alternative energy competition and overproduction, Chesapeake is fighting a losing battle.
Load More Articles